Chronic kidney disease in diabetes – who looks after these patients?

5th June 2021, Dr Chee L Khoo

Cardiovascular disease (CVD) and chronic kidney disease (CKD) are common complications in patients with type 2 diabetes (T2D). 70% of patients with T2D are likely to develop a CV disease while 40% of them will develop CKD. A significant proportion of patients with CKD will progress to kidney failure requiring renal dialysis or renal transplant. CVD and CKD both share pathophysiological mechanisms of damage but their management in general practice markedly differ. You see, almost all our patients who has CVD are referred to a cardiologist for shared management. On the other hand, most patients with T2D and CKD are not managed by a renal physician until they reach end stage renal failure. In other words, most patients with T2D and CKD are managed in primary care.  How well are you managing your patients with CKD in your practice?

Kidney Disease: Improving Global Outcomes (KDIGO) was established in 2003 with its stated mission to “improve the care and outcomes of patients with kidney disease worldwide through promoting coordination, collaboration, and integration of initiatives to develop and implement clinical practice guidelines”. KDIGO convened a group of experts to develop clinical practice guidelines informing the care of patients with or at risk of developing kidney diseases. Specifically, there are recommendations related to Diabetes Management in CKD and Top 10 Takeaways for Clinicians and 10 Takeaways for Patients for diabetes management in CKD. With many new agents targeting a variety of mechanistic approaches to improving outcomes for people with diabetes and kidney disease, it appears timely for KDIGO to commission a guideline in this area.

AstraZeneca, in conjunction with KDIGO is running a webinar looking at an insider’s view of the “2020 KDIGO Guidelines for Diabetes in CKD. Time for a change in clinical practice ”. It will be a robust panel discussion challenging clinical inertia and calling a time for change in clinical practice for patients with Diabetes and CKD. It is a topic very relevant to general practitioners.

This webinar will be led by Professors Christoph Wanner (Nephrologist) and Sophia Zoungas (Endocrinologist) both members of the 2020 KDIGO Guidelines for Diabetes in CKD Guidelines working group. Additionally, Professor Zoungas, as Chair of the Living evidence for diabetes steering committee in Australia, will put the Living Guidelines for Diabetes into context and discuss implementation into local Clinical Practice. Click here to register for the webinar.